GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Issuance of Debt

ArcticZymes Technologies ASA (FRA:B4V) Issuance of Debt : €0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is ArcticZymes Technologies ASA Issuance of Debt?

ArcticZymes Technologies ASA's Issuance of Debt for the three months ended in Mar. 2024 was €0.00 Mil.

ArcticZymes Technologies ASA's Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

ArcticZymes Technologies ASA Issuance of Debt Historical Data

The historical data trend for ArcticZymes Technologies ASA's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ArcticZymes Technologies ASA Issuance of Debt Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ArcticZymes Technologies ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ArcticZymes Technologies ASA Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ArcticZymes Technologies ASA's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ArcticZymes Technologies ASA (FRA:B4V) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ArcticZymes Technologies ASA (FRA:B4V) » Definitions » Issuance of Debt
Comparable Companies
OSL:HBC OSL:BGBIO OSL:CIRCA OSL:EXTX OSL:TRMED OSL:LYTIX OSL:ABS OSL:ABTEC OSL:PCIB OSL:SOFTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 HKSE:02269 MRNA XBRU:ARGX BNTX
Traded in Other Exchanges
AZT:Norway B4V:Germany
Address
Sykehusveien 23, Tromso, NOR, N-9294
Website
https://www.arcticzymes.com
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments that are Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA.

ArcticZymes Technologies ASA (FRA:B4V) Headlines

No Headlines